Business Context and Reporting Period
This Form 8-K Current Report was filed by China BAK Battery, Inc. (CBAK Energy Technology, Inc.) on October 8, 2013, regarding events occurring on October 3, 2013. The filing addresses a change in corporate governance and the resulting impact on the company's listing status on the NASDAQ Stock Market.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and regulatory compliance matters.
Material Changes
- Director Resignation: Jonathan Christopher Paugh resigned as a member of the Board of Directors and the Audit, Compensation, and Nominating and Corporate Governance Committees, effective immediately on October 3, 2013, due to personal reasons.
- Listing Non-Compliance: The resignation resulted in the Company failing to meet NASDAQ Listing Rules 5605(b)(1) and 5605(c)(2)(A). Specifically, the Board no longer has a majority of independent directors (currently 2 independent vs. 2 non-independent), and the Audit Committee has only two members instead of the required three.
Outlook, Risks, and Management Commentary
- Remediation Plan: The Company intends to elect a new independent director to fill the vacancies as soon as practicable.
- Cure Period: The Company notified NASDAQ of the noncompliance on October 7, 2013. It has been granted a cure period to regain compliance until the earlier of the next annual shareholders' meeting or October 3, 2014. If the next annual meeting occurs within 180 days of the resignation, the cure period is 180 days from that meeting.
- Risk of Delisting: Failure to regain compliance within the specified timeframe could result in the delisting of the Company's securities from the NASDAQ Stock Market.
Investor Verification Checklist
- Verify the timeline for the election of a new independent director to restore Board majority independence.
- Confirm the date of the next annual shareholders' meeting to determine the exact expiration of the NASDAQ cure period.
- Monitor subsequent filings for updates on the composition of the Audit Committee.
- Review the Company's stock trading status to ensure no suspension or delisting has occurred pending the cure period.